reslizumab

The new centre will be home to nearly 2,000 world-class researchers and scientists

This builds on a recently announced clinical collaboration between AstraZeneca and Summit to advance cancer treatments

Trixeo is the first and only triple-combination therapy approved in the EU for patients 12 years and older, independent of exacerbation history

Around 33,000 people in the UK are currently living with multiple myeloma, an incurable type of blood cancer

The results from a global phase 3 trial show the longest survival data ever reported in this setting

This is the first new regimen in more than a decade for first-line treatment for this type of breast cancer

Excessive sweating affects 1-5% of the population and can have a substantial impact on quality of life

The treatments are for eligible adults in England and Wales

The report forecasts a rise in cases in the US, the UK, Canada, Australia and Europe

Asthma affects over 360 million people worldwide, including over 40 million people in Europe

The company will gain a novel oral treatment for lung cancer

It is estimated that 3,300 women are diagnosed with cervical cancer in the UK each year